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Abstract
Background: No population study has explored the population distribution of adult asthma in the United Arab
Emirates (UAE). The objective is to estimate asthma prevalence in general population in UAE.
Methods: Using standard European Community Respiratory Health Survey (ECRHS) questionnaires and tools, this is
a cross-sectional assessment of a random sample of the population in established quotas of the seven Emirates in
the UAE. We surveyed 1,220 participants, of which 63.2% were male, and 20.1% were UAE Nationals, with a mean
(SD) age of 32.9 (14.1) years.
Results: Prevalence of individual respiratory symptoms from the ECRHS screening questionnaire in all participants
were generally ranging 8 - 10%, while participants 20-44 years presented lower prevalence in all symptoms (p <
0.05). The expected male:female ratio of reported wheezing and asthma attacks and its treatment by age was not
observed. Participating women reported more individual symptoms than men. Overall, there were 15.4% (95% C.I.
13.5 - 17.5) participants who fulfilled our screening criteria for asthma, while for consistency with ECRHS, there
were 12.1% (95% C.I. 10.4 - 14.1) participants who fulfilled the ECRHS asthma definition, being 9.8% (95% C.I. 7.8 -
12.2) of those 20-44 years, that is 8.6% of male and 11.8% of female young adults participating.
Conclusion: We conclude that asthma is common in the UAE, and gender differences are not observed in
reported asthma symptoms in young adults. This being the first population based study exploring the prevalence
of asthma and its determinants in the United Arab Emirates based on the ECRHS.
Background
Asthma is a complex, chronic disease that can manifest
at any age [1-3]. It has a very heterogeneous distribution,
and its prevalence has been increasing in all regions of
the World, likely due to a combination of factors, and
many unknowns remain in determining asthma causation
[4]. The disease represents a significant burden, not only
in terms of morbidity and reduced quality of life of
patients, but also in terms of healthcare cost [5,6].
Two international surveys of asthma prevalence have
greatly enhanced our knowledge of the distribution and
risk factors of asthma worldwide. First, the International
Study of Asthma and Allergies in Childhood (ISAAC) [7],
conducted in children of 6-7 and 13-14 years. Later, the
European Community Respiratory Health Survey
(ECRHS) [8], surveying that 20-44 years old, also led to
an increased understanding of the worldwide distribution
of asthma in young adults. Whilst Western Europe has
some of the highest prevalence rates of asthma in the
World, the ISAAC study found that the prevalence is not
only high in English-speaking countries like the UK, Aus-
tralia, New Zealand, and the US, but also identified new
hot spots with higher than expected asthma in
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Asia, and elsewhere [9]. There is a scarcity of data about
the distribution of asthma in the Gulf and near. Although
studies have been carried out, they involved relatively
small samples of patients selected from a limited number
of clinical or other institutional settings, and latest data is
not available. In UAE, in particular, there was an ISAAC
asthma center, which reported a prevalence of physician-
diagnosed asthma of 13% in 3,200 children aged 6-13
years in the seven Emirates of the UAE [10]. There have
been other small studies surveying asthmatic children.
However, to our knowledge no population study has
explored the population distribution of adult asthma in
the UAE. By using the screening questionnaire and tools
of the ECRHS, we aimed to determine the prevalence of
asthma symptoms in the general population in the UAE.
Methods
This is a cross-sectional assessment of a random sample
of the population of the UAE. The UAE lies within the
Arabian Gulf Region, with seven Emirates, namely Abu
Dhabi, Dubai, Sharjah, Ajman, Umm Al-Quwain, Ras
Al-Khaimah and Fujairah.
In 2009, the UAE population was estimated at 6 mil-
lion, of which fewer than 20% were UAE nationals or
Emiratis [11]. The country’s net migration rate stands at
22.98 per 1,000 inhabitants, the World’sh i g h e s t .T h e
population of the UAE has a skewed sex distribution con-
sisting of more than twice as many males as females, and
in the 15-65 years age group it has a male:female ratio of
2.743. The UAE’s gender imbalance is only surpassed by
other Arab countries in the Gulf region.
The methodology and objectives of the ECRHS have
been described previously [12]. Summarising, a random
sample of the population aged 20-44 years is contacted
and requested to complete a short screening question-
naire on respiratory symptoms. In a second phase of the
study a 20% random sub-sample of the sample popula-
tion and all remaining subjects reporting respiratory
symptoms in the screening questionnaire and not yet
included in the random sub-sample are asked to com-
plete a long questionnaire and other tests.
Population sampling and ethics
We included in the study male and female individuals of
a l la g e si nt h es e v e ne m i r a t e so ft h eU A E .T h es a m p l e
size was calculated with a precision level of 3%, popula-
tion size of 6 million, 95% Confidence Interval, and esti-
mated asthma prevalence of 13%. Overall, 1,225
individuals were selected according to the following pre-
determined sampling quotas by gender (66.5% males and
33.5% females); age (26.1% 0-19 year old, 72% 20-59 year
old and 1.9% ≥ 60 year old); residency status (20.1%
nationals and 79.8% expatriates);and geography within
the UAE (34.1% Abu Dhabi, 32.2% Dubai, 19.3% Sharjah,
5% Ajman, 1.2% Umm Al-Quwain, 5.1% Ras Al-Khaimah,
and 3.1% Fujairah). Given the absence of usable census
information in the UAE, interviews were conducted in
public locations across the seven emirates including town
centers, malls, outside mosques, and industrial areas
from late January 2010 to early March 2010. Apart from
the inability to signing the informed consent, there were
no exclusion criteria in this research. All participants
were informed of the voluntary nature of this research
and signed an informed written consent. This research
protocol was approved by Clinical Research Ethics
Authority of Dubai, UAE.
Questionnaire
The English versions of the screening and long ECRHS
questionnaires [12] were translated to Arabic, and partici-
pants were interviewed in a side-by-side bilingual version,
to assess the presence of respiratory symptoms, other con-
ditions, smoking, and treatments. As the interest was to use
the ECRHS screening questionnaire in the most sensitive
way as possible, any individual was considered symptomatic
of asthma if he/she answered YES to any of the following
questions: “Have you had wheezing or whistling in your
chest at any time in the last 12 months?”,o r“Have you
been coughing constantly for more than 3 weeks in any
time in your life?”,o r“Have you had an attack of asthma in
the last 12 months?”,o r“Do you have any nasal allergies
including hay fever?”. In addition any smoker or anyone
answering YES to 50% of the eight questions of the ECRHS
screening questionnaire was qualified for the survey.
All interviews were administered by an interviewer,
and participants had the option to answer questions in
t h el a n g u a g et h e yw e r em o r ec o m f o r t a b l ew i t h ,e i t h e r
Arabic or English. Results of the ECRHS screening ques-
tionnaire only are presented in this report.
Statistical analysis
Data are presented as mean and standard deviation (SD)
for continuous variables, or percentage for qualitative vari-
ables, as appropriate. Differences within groups were com-
pared with analysis of variance (ANOVA) for continuous
variables, and Chi
2 for categorical variables. The preva-
lence of asthma symptoms and their 95% confidence inter-
vals (95% C.I.) was estimated for all participants, and by
gender and age bands. Due to the sampling quotas by age,
and also to compare directly with ECRHS centers, the
most relevant results are also presented for participants
20-44 years, and younger and older ages. A p <0 . 0 5w a s
considered statistically significant.
Results
The total number of respondents interviewed with
sociodemographic data was 1,220 (Figure 1), of which
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Page 2 of 863.2% were male, and 20.1% were UAE Nationals, with a
mean (SD) age of 32.9 (14.1) years, all according to the
above mentioned quotas. In detail, sampling percentages
of participants per Emirate was 34.1% Abu Dhabi, 32.2%
Dubai, 19.3% Sharjah, 5.0% Ajman, 1.3% Umm Al-
Quwain, 1% Ras Al-Khaimah, and 3.1% Fujairah.
Results by gender and age are presented for partici-
pants 20-44 years, younger and older ages (Table 1).
Prevalence of individual respiratory symptoms accord-
ing to the ECRHS screening questionnaire in all partici-
pants were ranging from 8 to 10%, except for, lower for
nasal allergies (6.8%) (Table 2). However, when stratified
by age band, it can be seen that in participants younger
than 20 years, as well as those older than 44 years, pre-
valence of nearly all symptoms are 10% or higher, while
those participants 20-44 years presented lower preva-
lence in all symptoms (p < 0.05).
We explored the male:female ratio of reported wheez-
ing and of asthma attacks and its treatment by age (Fig-
ure 2). The classical inversion of the male:female ratio
in adolescence was not observed; in girls 5-15 years
wheezing and asthma attacks were more common than
in boys, while prevalence of these symptoms were evenly
reported up to the age of 60 years and older. Surpris-
ingly, reported asthma treatment showed no gender
ratio and was unchanged in all age bands, namely 9.3%
in participants younger than 20 years, 6.6% in partici-
pants 20-44 years, and 10.3% in participants older than
44 years (Table 2).
These respiratory symptoms according to the ECRHS
screening questionnaire are next presented in partici-
pants 20-44 year, by gender (Table 3). It can be seen
that all symptoms were reported more frequently in
female than male, differences being statistically signifi-
cant only for “Woken up by an attack of coughing” and
for “Nasal allergies (including hay fever)” (p < 0.05).
 
No response (n = 5) 
No age (n = 9) 
Source population of the UAE 
(n = 6 million) 
Study Sample Contacted  
(n = 1,225) 
Completed ECHRS-Screening 
Questionnaire (n = 1,220) 
"YES" to 
Q3 “awake by 
shortness of 
breath”,   
Q5 “asthma”, or 
Q6 “medication” 
 
(n=148) 
"YES" to 
Q1 “wheezing”, 
Q4 “coughing”, 
Q5 “asthma”,  
Q7 “nasal”, or 
50% of all items 
 
(n=188) 
"NO" to  all 
 
(n=1,032) 
Figure 1 CONSORT flow-chart of participants.
Table 1 Demographic characteristics of participants, by age band
Variable 19 yr or less
n = 237
(19.4%)
20 to 44 yr
n = 702
(57.5%)
45 yr or more
n = 281
(23.0%)
ALL
n = 1220
Male gender, n (%) 139 (58.6%) 440 (62.7%) 192 (68.3%) 771 (63.2%)
Age in years, mean (SD) 13.8 (4.9) 31.6 (7.0) 52.3 (5.5) 32.9 (14.1)
Table 2 Symptoms according to the ECRHS screening questionnaire in participants, by age band
ECRHS screening questionnaire symptoms within the last 12 months,
n (%)
19 yr or less
n = 237
(19.4%)
20 to 44 yr
n = 702
(57.5%)
45 yr or more
n = 281
(23.0%)
ALL
n = 1220
Wheezing/whistling 31 (13.1%) 57 (8,1%) 34 (12.1%) 122 (10.0%)
Wheezing with breathlessness 27 (11.4%) 50 (7.1%) 32 (11.4%) 109 (8.9%)
Wheezing without a cold 24 (10.1%) 43 (6.1%) 31 (11.0%) 98 (8.0%)
Woken up with chest tightness 32 (13.5%) 53 (7.5%) 34 (12.1%) 119 (9.8%)
Woken up by shortness of breath 30 (12.7%) 51 (7.3%) 30 (10.7%) 111 (9.1%)
Woken up by an attack of coughing 30 (14.8%) 59 (8.4%) 33 (11.7%) 127 (10.4%)
Attack of asthma 28 (11.8%) 42 (6.0%) 27 (9.6%) 97 (8.0%)
Currently taking asthma medications 22 (9.3%) 46 (6.6%) 29 (10.3%) 97 (8.0%)
Nasal allergies (including hay fever) 22 (9.3%) 46 (6.6%) 15 (5.3%) 83 (6.8%)
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participants who fulfilled our screening criteria for
asthma (Figure 1). These asthmatics were more fre-
quently male (56.5%) but there were no significant
differences by age in male versus female asthmatics
(Table 4). As per the results in the general population,
there were neither clinical nor statistical differences in
the distribution of individual respiratory symptoms by
A)
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Figure 2 Prevalence of wheezing (A), asthma attack (B) and asthma medication (C) by age, in male and female.
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out a cold” (p < 0.05) (Table 4).
For consistency with ECRHS sampling methodology,
results in those participants responding YES to the fol-
lowing three questions: “Have you been woken by an
attack of shortness of breath at any time in the last 12
months?”,o r“Have you had an attack of asthma in the
last 12 months?”,o r“Are you currently taking any med-
icine (including inhalers, aerosols or tablets) for
asthma?” are presented in Table 5. There were 146
(12.1%, 95% C.I 10.4 - 14.1) participants who fulfilled
the ECRHS asthma definition in all ages. Specifically,
the ECRHS asthma prevalence in those 702 participants
with 20-44 years was 9.8% (95% C.I. 7.8 - 12.2), that is
in males 8.6% (95% C.I. 6.2 - 11.7) and in females 11.8%
(95% C.I. 8.2 - 16.4) participating.
Compared to results in Table 4, these ECRHS-defini-
tion asthmatics were also more frequently male
(57.5%), but again there were no significant differences
by age in male versus female ECRHS-definition asth-
matics. The distribution of individual respiratory symp-
toms by gender in these asthmatics were evenly
distributed, again except for “Wheezing without a
cold” (p < 0.05) (Table 5)
Finally, an approximation to asthma incidence is pre-
sented in Figure 3, from birth to age 50 years. As
expected, the reported age of the first attack of asthma
occurred more frequently in childhood and adolescence,
but in males there was a peak in asthma incidence
(10%) after the age of 20 years, while in females there
was another peak in asthma incidence (7%) after the age
of 25 years.
Table 3 Symptoms according to the ECRHS screening questionnaire in participants 20-44 yr, by gender
ECRHS screening questionnaire symptoms within the last 12 months, n (%) 20 to 44 yr
male
(n = 440)
20 to 44 yr
female
(n = 262)
p
Wheezing/whistling 30 (6.8%) 27 (10.3%) 0.069
Wheezing with breathlessness 26 (5.9%) 24 (9.2%) 0.253
Wheezzing without a cold 23 (5.2%) 20 (7.6%) 0.255
Woken up with chest tightness 28 (6.4%) 25 (9.5%) 0.080
Woken up by shortness of breath 31 (7.0%) 20 (7.6%) 0.440
Woken up by an attack of coughing 29 (6.6%) 30 (11.5%) 0.034*
Attack of asthma 21 (4.8%) 21 (8.0%) 0.058
Currently taking asthma medications 26 (5.9%) 20 (7.6%) 0.230
Nasal allergies (including hay fever) 21 (4.8%) 25 (9.5%) 0.011*
“*“ Significant p-value
Table 4 Characteristics of those responding “YES” to Q1 “wheezing”,Q 4“coughing”,Q 5“asthma”,o rQ 7“nasal”
according to the ECRHS screening questionnaire (n = 184)
male
(n = 104)
female
(n = 80)
ALL
n = 184
p
Age in years, mean (SD) 34.0 (15.4) 31.3 (15.7) 32.8 (15.5) 0.247
Age band, n (%) 0.309
￿ 19 yr or less 27 (26.0%) 18 (22.5%) 45 (24.5%)
￿ 20 to 44 yr 47 (45.2%) 45 (56.3%) 92 (50.0%)
￿ 45 yr or more 30 (28.8%) 17 (21.3%) 47 (25.5%)
ECRHS screening questionnaire symptoms within the last 12 months, n (%)
Wheezing/whistling 68 (65.4%) 57 (67.9%) 125 (66.5%) 0.758
Wheezing with breathlessness 60 (57.7%) 51 (60.7%) 111 (59.0%) 0.916
Wheezzing without a cold 59 (56.7%) 39 (46.4%) 98 (52.1%) 0.043*
Woken up with chest tightness 57 (54.8%) 44 (52.4%) 101 (53.7%) 0.770
Woken up by shortness of breath 59 (56.7%) 42 (50.0%) 101 (53.7%) 0.380
Woken up by an attack of coughing 70 (67.3%) 60 (71.4%) 130 (69.1%) 0.634
Attack of asthma 52 (50.0%) 47 (56.0%) 99 (52.7%) 0.464
Currently taking asthma medications 54 (51.9%) 41 (48.8%) 95 (50.5%) 0.769
Nasal allergies (including hay fever) 45 (43.3%) 40 (47.6%) 85 (45.2%) 0.559
“*“ Significant p-value
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We report in here the first population study assessing
the distribution of adult asthma in the UAE. By using
standard ECRHS questionnaires and tools, we deter-
mined that the prevalence of asthma (see Methods for
definition) is at least 9.8% in young adults 20-44 years,
and participating women reported more individual
respiratory symptoms than men. As previously reviewed,
only our national ISAAC center reported standard data
on asthma in the UAE previously, but adult asthma
information was yet unavailable. Recently, Alsowaidi et
al. reported indirectly that in a randomly selected, age-
stratified cohort of adolescent school children and their
caretakers in the UAE, with a median age of 30 years
(range 8 - 93 years), a 7.3% prevalence of comorbid
allergic rhinitis asthma, lower in immigrants and with
increasing age [13].
Our group recently participated in an international
endeavor to explore the insights and realities of already
diagnosed and treated asthmatics within the Gulf region
[14], and results are also available for the UAE only
[15]. Similar to asthmatics in other regions, it was con-
cluded from surveying 200 asthmatics in the UAE that
asthma burden and uncontrolled asthma were frequent,
with 52.8% of the children and 17.1% of the adults miss-
ing school and work due to asthma in the past year,
respectively. The percentage of Emirati asthmatics that
had emergency room visits within the past year was
27.5%, and 4% were hospitalized. Only 5.5% used
inhaled corticosteroids in the past year, and 47.5% were
on short-acting b2-agonists. Contrary to our results in
here on asthma symptoms, 85% of participating asth-
matics were male.
Strengths of our research include an appropriate sam-
ple size for a prevalence study, surveying all seven
Table 5 Characteristics of those responding “YES” to Q3 “shortness of breath”,Q 5“asthma”,o rQ 6“treatment of
asthma”, according to the ECRHS main questionnaire (n = 146)
male
(n = 84)
female
(n = 62)
ALL
n = 146
p
Age in years, mean (SD) 30.8 (16.7) 33.9 (16.2) 32.6 (16.4) 0.263
Age band, n (%) 0.711
￿ 19 yr or less 22 (26.2%) 17 (24.4%) 39 (26.7%)
￿ 20 to 44 yr 38 (45.2%) 31 (50.0%) 69 (47.3%)
￿ 45 yr or more 24 (28.6%) 14 (22.6%) 38 (26.0%)
ECRHS screening questionnaire symptoms within the last 12 months, n (%)
Wheezing/whistling 59 (70.2%) 49 (76.6%) 108 (73.0%) 0.457
Wheezing with breathlessness 53 (63.1%) 45 (70.3%) 98 (66.2%) 0.649
Wheezzing without a cold 52 (61.9%) 34 (53.1%) 86 (58.1%) 0.037*
Woken up with chest tightness 56 (66.7%) 38 (59.4%) 94 (63.5%) 0.392
Woken up by shortness of breath 67 (79.8%) 44 (68.8%) 111 (75.0%) 0.131
Woken up by an attack of coughing 54 (64.3%) 44 (68.5%) 98 (66.2%) 0.603
Attack of asthma 52 (61.9%) 47 (73.4%) 99 (66.9%) 0.161
Currently taking asthma medications 56 (66.7%) 42 (65.6%) 98 (66.2%) 1.000
Nasal allergies (including hay fever) 29 (34.5%) 27 (42.2%) 56 (37.8%) 0.394
“*“ Significant p-value
Figure 3 Self-reported age at first attack of asthma in male
and female asthmatics (n = 110).
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and methodology. However, some limitations are worth
exploring. Given the reality of the UAE, with so many
expatriates and immigrants, and the absence of appro-
priate census, it was decided to invite randomly and sur-
vey participants in public locations, rather than a door-
to-door, random-digit dialing, or other sampling
procedure.
Exploring the natural history of asthma in UAE is of
interest, as we detected a substantial number of female
asthmatics, and an absence of the expected male:female
ratio of asthma incidence, to be reverted after adoles-
cence. The gender differences in prevalence of wheeze
and asthma attack did not reach statistical significance
because the true differences appear to be quite small to
be significantly detected based on our sample sizes of
males and females. For example, using our sample sizes,
the power to detect a difference in the prevalence of
asthma attack between males and females that is of the
order of 6% (corresponding to the observe differences in
prevalence, see Table 4) is only 10% while the power to
detect a difference in the prevalence of asthma attack
between 20-44 years old males and females that is of
the order of 3% (corresponding to the observed differ-
ence, see Table 3) is 31%. Very recently, it was reported
p o o l i n gd a t ao f4 8E C R H Sc e n t e r sf r o m2 2c o u n t r i e s
that there was no gender difference in asthma severity
when comparing two repeat surveys completed in 1993
and 2002, but it was suggested that asthma severity
might be less stable in women than in men [16]. Further
research on the timing of these symptoms and perhaps a
relationship with active and passive smoking patterns,
and exposure to known asthma triggers and other local
exposures, are worth considering.
We conclude that asthma in the study sample of the
UAE population is frequent, 8.6% in male and 11.8% in
female young adults 20-44 years., and that gender differ-
ences in asthma deserve further research.
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